PATENT CLAIM ANALYSIS

Application Number: 16108727
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "249000"]

Abstract:
The invention generally relates to compositions for inducing vasoconstriction. The compositions comprise highly selective alpha-2 adrenergic receptor agonists, at low concentrations, such as below 0.05% weight by volume. The compositions preferably comprise brimonidine. The compositions preferably have pH from about 4.0 to about 7.5.

Claim (Index 4):
The method of  claim 1 , wherein the composition is formulated as an ocular drop.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.37838
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12460968', '12460970', '12460941', '12460942', '14044929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.822345636803743
- 35 USC 102 Novelty (BERT): 0.5640734526430391
- Combined Prediction Score: 0.7965184183876726
- Mean Citation Score: 482.61016
- Max Citation Score: 522.8359
- Similarity Product: 289.03652471103067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test